IL-6 signaling is presumed to be associated with the development of lymphoma, and it has been suggested that the blockade of IL-6 induced by TCZ might reduce lymphoma development, even among patients with RA taking MTX [5]. The gene discussed is IL6; the disease is rheumatoid arthritis.